University of Kansas School of Medicine/Dept. of Psychiatry — Kansas City, Kansas

University of Kansas School of Medicine/Dept. of Psychiatry is a clinical research site located in Kansas City, Kansas, United States 66160-7341.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of Kansas School of Medicine/Dept. of Psychiatry has participated in 1 clinical trials.

Therapeutic areas: Obsessive Compulsive Disorder.

Sponsors: Pfizer's Upjohn has merged with Mylan to form Viatris Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Kansas School of Medicine/Dept. of Psychiatry?

University of Kansas School of Medicine/Dept. of Psychiatry has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Kansas School of Medicine/Dept. of Psychiatry conducted?

University of Kansas School of Medicine/Dept. of Psychiatry has 1 clinical trials on record. Their work covers Obsessive Compulsive Disorder.

Is University of Kansas School of Medicine/Dept. of Psychiatry accredited by Crixeo Health?

University of Kansas School of Medicine/Dept. of Psychiatry has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Kansas School of Medicine/Dept. of Psychiatry?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.